🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of a High-resolution Program for the Prevention of Suicidal Behavior in At-risk Adults: a Quasi-experimental Ambispective Cohort Study

RecruitingNAAges 18 Years - anyAllUniversity of Salamanca
NCT07655986 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Suicidal behavior represents a major public health problem worldwide. According to the World Health Organization (WHO), approximately 720.000 people die by suicide annually, and many more attempt it. Suicide is a personal tragedy associated with extreme suffering that has a serious impact on the deceased's immediate circle and on society as a whole. In this context, there is an urgent need to design effective and humane intervention strategies that offer an evidence-based, preventive, specialized, and community-oriented response to suicidal behavior. Objective: To evaluate the impact of a multidisciplinary, specialized, and high-resolution program for the prevention of suicidal behavior in adults aged 18 and over in the Salamanca Health Area. Methods: A quasi-experimental, ambispective cohort study with two parallel groups: an intervention group, receiving the specific suic

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients ≥ 18 years of age. * No prior active follow-up by the mental health team. * Prior stabilization by the emergency psychiatry team. * Columbia Severity Rating Scale (C-SSRS) score corresponding to moderate-to-high risk. * Absence of criteria for urgent hospital admission. * Signed informed consent. Exclusión Criteria: * Self-harm without suicidal intent. * Mild suicide risk (mild C-SSRS). * Extremely high suicide risk requiring urgent hospital admission. * Patient under active follow-up at another mental health unit.
💊

What it tests

  • PPS; SUICIDE PREVENTION PROGRAM
📍

Where

1 site
Hospital Universitario de Salamanca
Salamanca, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy